Spyre Therapeutics, Inc. <SYRE.O>: Wells Fargo Raises Target Price to $115 From $90
SYRE•Related News
DaVita Inc <DVA.N>: Bofa Global Research Raises Price Objective to $170.00 From $145.00
DVA•
Aramark declares quarterly dividend of $0.12 a share
ARMK•
New York Times posts slower digital subscriber growth, shares slump
NYT•
Paramount Skydance: BofA Global Research cuts price objective to $9.00 from $11.00
PSKY•
American Well <AMWL.N>: Morgan Stanley raises target price to $13.00 from $6.50
AMWL•